240 related articles for article (PubMed ID: 9115573)
1. Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice.
Saï P; Damagé C; Rivereau AS; Hoeltzel A; Gouin E
J Autoimmun; 1996 Dec; 9(6):713-22. PubMed ID: 9115573
[TBL] [Abstract][Full Text] [Related]
2. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
[TBL] [Abstract][Full Text] [Related]
3. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Saï P; Rivereau AS
Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
[TBL] [Abstract][Full Text] [Related]
4. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
6. Active suppression of diabetes after oral administration of insulin is determined by antigen dosage.
Bergerot I; Fabien N; Mayer A; Thivolet C
Ann N Y Acad Sci; 1996 Feb; 778():362-7. PubMed ID: 8610991
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
Wang H; Li Y; Sun Q; Yang G
Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
[TBL] [Abstract][Full Text] [Related]
8. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.
Bergerot I; Fabien N; Maguer V; Thivolet C
J Autoimmun; 1994 Oct; 7(5):655-63. PubMed ID: 7840857
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Zhang ZJ; Davidson L; Eisenbarth G; Weiner HL
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10252-6. PubMed ID: 1946445
[TBL] [Abstract][Full Text] [Related]
11. The influence of oral insulin on the development of autoimmune diabetes in NOD mice fed a hypoallergenic diet.
Shehadeh N; Weis R; Teninboum G; Benderly A; Etzioni A; Shamir R
Diabetes Nutr Metab; 2004 Feb; 17(1):1-5. PubMed ID: 15163117
[TBL] [Abstract][Full Text] [Related]
12. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.
Bergerot I; Ploix C; Petersen J; Moulin V; Rask C; Fabien N; Lindblad M; Mayer A; Czerkinsky C; Holmgren J; Thivolet C
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4610-4. PubMed ID: 9114038
[TBL] [Abstract][Full Text] [Related]
13. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
15. Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial.
Karges W; Hammond-McKibben D; Cheung RK; Visconti M; Shibuya N; Kemp D; Dosch HM
Diabetes; 1997 Apr; 46(4):557-64. PubMed ID: 9075794
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
17. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes.
Bergerot I; Fabien N; Maguer V; Thivolet C
Clin Exp Immunol; 1995 Nov; 102(2):335-40. PubMed ID: 7586687
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
[TBL] [Abstract][Full Text] [Related]
20. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
